Status:
WITHDRAWN
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women
Lead Sponsor:
University of Arizona
Conditions:
Triple Negative Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
A key tenet of this project is that of reaching translational human diagnosis and biomarker end points. To lay a foundation and make progress towards these translational goals, investigators will addr...
Detailed Description
The intended goal of this Project is to develop epigenetic biomarkers to monitor the role of obesity and ethnicity on he development of triple negative breast cancer (TNBC). The proposed approach will...
Eligibility Criteria
Inclusion
- Hispanic or NHW women
- ≥ 18 years of age
- scheduled for a breast procedure as standard of care treatment - benign breast surgery or prophylactic mastectomy\\
- Newly diagnosed TNBC - Patients with TNBC will be eligible regardless of whether their treatment plan is surgery first or chemotherapy first (neoadjuvant chemotherapy)
- Eligible non-white women could be included
Exclusion
- BRCA1/2 mutation carriers
- Family history of breast cancer in a first-degree relative and have NOT had genetic testing for BRCA1/2
- Patients who have already undergone radiation or chemotherapy
- Pregnant women
- Male
- Prisoners
Key Trial Info
Start Date :
August 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04291950
Start Date
August 30 2022
End Date
August 30 2025
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona Cancer Center
Tucson, Arizona, United States, 85724